GLP-1 Drugs Linked to Lower Epilepsy Risk in Diabetes Patients
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — GLP-1 receptor agonists were linked to a lower risk of developing epilepsy in adults with type 2 diabetes, a large US study showed. Compared with DPP-4 inhibitors, the use of GLP-1 receptor agonists was associated with a 16% lower risk…
:max_bytes(150000):strip_icc()/Health-GettyImages-1834945489-fff8e19ba32040a0be2aa755c7033760.jpg?w=390&resize=390,220&ssl=1 "How Often Is It Actually Safe to Donate Blood?")
